Skip to main content
. 2019 Oct 22;41(17):1653–1661. doi: 10.1093/eurheartj/ehz714

Figure 3.

Figure 3

Forest plots showing the results from the interaction analyses of the impact of secondary prevention medication on mortality overall and for selected subgroups. (A) Statins and β-blockers; (B) RAAS inhibitors and platelet inhibitors. RAAS, renin-angiotensin-aldosterone system.